The Chamber: ‘One More Bullet in J&J’s Gun’
In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and the U.S. Chamber of Commerce (the Chamber). The U.S. Chamber of Commerce is not a government entity, but a powerful group of lobbyists, the largest in the nation. Plaintiff’s lawyers point out […]
Sheller hits #1 Top 50 Verdicts in Pennsylvania for 2016
Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy who grew female-like breasts after taking the antipsychotic drug Rispderal. The unprecedented $70 Million verdict in damages for physical disfigurement and emotional […]
High Court Won’t Hear Sheller Dispute with FDA over Risperdal
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over government actions remain unclear By Dana A. Elfin A Philadelphia-based law firm has hit the end of the road in its bid […]
Researchers Concerned About Over-Prescription of Risperdal
The most recent study published on the use of antipsychotics, such as Risperdal, Zyprexa and Seroquel, in children with ADHD has researchers concerned that there may be an over-prescription problem. The study published January 19, 2017 in The Canadian Journal of Psychiatry shows the same dramatic increase in use of antipsychotics prescribed off-label in children with ADHD, ages 1 […]
Sheller’s New Book Available, Read the First Chapter
NOW AVAILABLE ONLINE AND BY REQUEST AT YOUR LOCAL BOOKSTORE — Click here to buy the book online — PHARMAGEDDON: A Nation Betrayed A National Trial Lawyer Reveals an Industry Spinning Out of Control by Stephen A. Sheller, Esq. with New York Times best-selling author Sidney D. Kirkpatrick […]
Sheller on “Full Measure” TV: Update
The television program “Full Measure with Sharyl Attkisson” updated their segment “Bitter Pill” that featured the story of the Sheller firm’s Risperdal litigation. The updated report included the recent $70 million verdict. See the updated broadcast of “Bitter Pill” with the interview of Stephen Sheller here: http://fullmeasure.news/news/politics/bitter-pills-08-02-2016 See the Sheller.com previous post on the segment […]
$70M Risperdal Verdict
In the Philly Inquirer July 2, 2016: Philadelphia jury pins $70m verdict on Janssen for its Risperdal drug A Philadelphia jury found Friday that the antipsychotic drug Risperdal caused a Tennessee boy to grow breasts and imposed a $70 million verdict on its manufacturer, Janssen Pharmaceuticals. Lawyers for the boy argued that scientists for the […]
Sheller Appears on “Full Measure” TV
Attorney Stephen Sheller appeared on the television program “Full Measure’ May 1, 2016 discussing Risperdal gynecomastia cases. Sheller was interviewed by Sharyl Attkisson, who previously covered the Risperdal story with attorney Sheller for CBS news, in a video that has now been watched nearly 60,000 times on the CBS and Sheller YouTube channels. Full Measure is the […]
Sheller Risperdal Fight, Philadelphia Weekly
Stephen Sheller is regarded as the “Legal Forest Gump” by Liz Spikol, Philadelphia Weekly, in the article “Mind Control”, a story that reveals raw, unconcealed experience with antipsychotic drugs like Risperdal and poses a key question – why are we giving antipsychotic drugs to thousands of kids who don’t even need them? “Philadelphia is ground zero for much of […]
Plaintiffs 3-for-4 in Philadelphia Risperdal trials
Plaintiffs 3-for-4 in Philadelphia Risperdal trials, confident punitive damages will be reintroduced If the results of the first trials are any indication, Janssen Pharmaceuticals might find itself with a hefty price tag connected to more than 1,600 Risperdal cases currently pending in Philadelphia, even without the prospect of paying punitive damages – though an appeal […]
